Skip to main content

Table 5 The association between SNHG16 expression and DFS/PFS

From: Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis

Study (year)

No. of patient

Cancer type

Outcome

HR (95% CI)

P

Lu (2018) [16]

48

Glioma

PFS

3.167 (1.552–6.231)

0.021

Han (2018) [14]

66

Non-small cell lung cancer

DFS

4.505 (1.980–10.309)

<0.001

  1. Abbreviations: PFS progression free survival, DFS disease free survival, HR hazard ratio, 95% CI 95% confidence interval